68 related articles for article (PubMed ID: 2650134)
1. Correlation of HLA class II antigen induction and cellular infiltration in renal allograft rejection.
McWhinnie DL; Fuggle SV; Azevedo LS; Carter NP; Morris PJ
Transplant Proc; 1989 Feb; 21(1 Pt 1):320-1. PubMed ID: 2650134
[No Abstract] [Full Text] [Related]
2. Immunohistological analysis of renal allograft biopsies from cyclosporin-treated patients. Induced HLA-class II antigen expression does not exclude a diagnosis of cyclosporin nephrotoxicity.
Fuggle SV; McWhinnie DL; Morris PJ
Transpl Int; 1989 Oct; 2(3):123-8. PubMed ID: 2679626
[TBL] [Abstract][Full Text] [Related]
3. HLA class II induction and cellular infiltration are effectively suppressed by triple therapy in renal allografts.
McWhinnie DL; Fuggle SV; Azevedo LS; Jones RM; Morris PJ
Transplant Proc; 1987 Oct; 19(5):3628-9. PubMed ID: 3313873
[No Abstract] [Full Text] [Related]
4. Monitoring of renal allograft rejection with fine needle aspiration biopsy and serum C-reactive protein determinations.
Kaden J; Strobelt V; Oesterwitz H; Groth J; May G; Eichler C
Transplant Proc; 1987 Feb; 19(1 Pt 2):1657. PubMed ID: 3274398
[No Abstract] [Full Text] [Related]
5. Assessment of fine needle aspiration biopsies from renal transplants using monoclonal antibodies as lymphocyte markers.
Waugh J; Bishop A; Hall BM; Philips J; Duggin G; Tiller D; Sheil A; Horvath J
Transplant Proc; 1986 Apr; 18(2):267-9. PubMed ID: 3515663
[No Abstract] [Full Text] [Related]
6. Expression of MHC class I-related Chain B (MICB) molecules on renal transplant biopsies.
Quiroga I; Salio M; Koo DD; Cerundolo L; Shepherd D; Cerundolo V; Fuggle SV
Transplantation; 2006 Apr; 81(8):1196-203. PubMed ID: 16641608
[TBL] [Abstract][Full Text] [Related]
7. Relationship between cellular and molecular markers of inflammation in human kidney allograft rejection.
von Willebrand E; Häyry P
Transplant Proc; 1987 Feb; 19(1 Pt 2):1644-5. PubMed ID: 3079030
[No Abstract] [Full Text] [Related]
8. Renal target structures in acute allograft rejection.
Leszczynski D; Laszczynska M; Halttunen J
Transplant Proc; 1987 Feb; 19(1 Pt 1):378. PubMed ID: 3079159
[No Abstract] [Full Text] [Related]
9. Expression of major histocompatibility complex (MHC) class II antigens and HLA-DR incompatibility.
Oba S; Toma H; Takahashi K; Ota K
Transplant Proc; 1989 Feb; 21(1 Pt 1):323-4. PubMed ID: 2650137
[No Abstract] [Full Text] [Related]
10. Class II major histocompatibility complex antigens on cardiac endothelium: an early biopsy marker of rejection in the transplanted human heart.
Caforio AL; Bottazzo GF; McKenna WJ; Counihan PJ; Burke M; Poloniecki J; Davies MJ; Pepper JR
Transplant Proc; 1990 Aug; 22(4):1830-3. PubMed ID: 2202130
[No Abstract] [Full Text] [Related]
11. HLA-class II antigen induction does not exclude a diagnosis of cyclosporine nephrotoxicity.
Fuggle SV; McWhinnie DL; Morris PJ
Transplant Proc; 1989 Feb; 21(1 Pt 2):1525-6. PubMed ID: 2652491
[No Abstract] [Full Text] [Related]
12. Class II antigens and interleukin 2 expression in renal allograft recipients.
Glapinski T; Lao M; Wasik M; Lagodzinski Z; Nowaczyk M; Gorski A
Transplant Proc; 1989 Feb; 21(1 Pt 1):319. PubMed ID: 2650133
[No Abstract] [Full Text] [Related]
13. Mechanisms in organ allograft rejection. An experimental and clinical study.
Claesson K
Scand J Urol Nephrol Suppl; 1987; 103():1-42. PubMed ID: 3321417
[TBL] [Abstract][Full Text] [Related]
14. Expression of class I and class II major histocompatibility complex (MHC) antigens in rejecting human heart grafts.
Ippoliti G; Lazzaro A; Goggi C; Malavasi F; Di Franco L; Martinelli L; Ascari E; Vigano' M
Transplant Proc; 1989 Feb; 21(1 Pt 1):445-6. PubMed ID: 2650172
[No Abstract] [Full Text] [Related]
15. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report.
Süsal C; Döhler B; Opelz G
Hum Immunol; 2009 Aug; 70(8):569-73. PubMed ID: 19375472
[TBL] [Abstract][Full Text] [Related]
16. Expression of class II antigen: marker for rejection?
O'Brien J; Horsburgh T; Veitch PS
Transplant Proc; 1987 Feb; 19(1 Pt 1):211-2. PubMed ID: 3152689
[No Abstract] [Full Text] [Related]
17. Evaluation of class II major histocompatibility complex antigen expression for the differential diagnosis of cyclosporine A nephrotoxicity from kidney graft rejection.
Barrett M; Milton AD; Barrett J; Taube D; Bewick M; Parsons VP; Fabre JW
Transplant Proc; 1987 Feb; 19(1 Pt 2):1769-71. PubMed ID: 3152634
[No Abstract] [Full Text] [Related]
18. Transplantation antigens on renal endothelium.
Paul LC; Baldwin WM; Van Es LA
Neth J Med; 1982; 25(7):208-14. PubMed ID: 6755279
[No Abstract] [Full Text] [Related]
19. Plasma soluble interleukin-2 receptor (IL-2RS) level and activation markers in blood in the follow-up of renal allograft patients.
Malcus C; Pouteil-Noble C; Touraine F; Raffaele P; Touraine JL
Transplant Proc; 1990 Aug; 22(4):1865-6. PubMed ID: 2389463
[No Abstract] [Full Text] [Related]
20. Expression of HLA-DR, -DQ, and -DP antigens on renal tubular cells during rejection episodes.
Russ GR; Pascoe V; d'Apice AJ; Seymour AE
Transplant Proc; 1986 Apr; 18(2):293-7. PubMed ID: 3515666
[No Abstract] [Full Text] [Related]
[Next] [New Search]
